COMMENTS ON “Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study”

Elsevier, Journal of The American Academy of Dermatology

Journal article published in 2018 by Ennio Giulio Favalli, Fabrizio Conti, Fabiola Atzeni, Carlo Selmi, Salvatore D’Angelo

, Roberto Caporali, Florenzo Iannone

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by